one hundred thirty-three patients with advanced pancreatic adenocarcinoma and measurable disease were treated with 5-fluorouracil ( 5-fu ) plus doxorubicin plus mitomycin c ( fam ) , streptozotocin plus mitomycin c plus 5-fu ( smf ) in the regimen originally reported , and streptozotocin plus mitomycin c plus 5-fu with 5-fu and streptozotocin administered in five-day courses .
C0279188
doxorubicin
C0002475
mitomycin c